← AI Health Hub

Machine Learning 2 min read

Chipiron Secures $17 Million for Portable MRI Development

Chipiron raises $17 million for portable MRI development, aiming to enhance accessibility in local care centers and clinics. πŸ₯πŸ’°

Yusuf Yesil, MD, MIS

Chipiron Secures $17 Million for Portable MRI Development

Funding Overview

Chipiron, a deeptech startup focused on ultra-low MRI technology, has successfully raised $17 million in a Series A funding round. The round was led by Blast, with participation from the EIC Fund and iXcore, alongside support from France2030 (SGI), the EIC Accelerator (European Commission), and Bpifrance.

Company Mission

Chipiron’s goal is to enhance access to MRIs by developing a lightweight, portable machine suitable for:

  • Local care centers
  • Private clinics
  • Mobile units

The funds will be utilized to finalize the development of a miniaturized MRI scanner and to create the first prototypes for hospital deployment, with clinical trials expected to start in 2026.

CEO Statement

Evan Kervella, CEO and co-founder of Chipiron, stated, “This fundraising marks a major turning point for Chipiron, as it validates both our technological approach and the clinical impact we aim to achieve. Thanks to the trust of our investors, we now have the means to complete our research and development phase and begin clinical investigations in hospitals as early as next year.”

Market Context

Chipiron’s previous funding includes:

  1. $1.1 million in a pre-seed round in 2021
  2. $1.1 million in non-dilutive funding between 2022 and 2023
  3. $2.7 million in a seed round led by Exor Ventures and Unruly Capital in 2023

The MRI market is valued at approximately $10 billion, with Europe accounting for $2.5 billion of that total.

Competitive Landscape

Other notable companies in the MRI sector include:

  • Hyperfine: Collaborated with NVIDIA to enhance portable imaging technology.
  • Springbok Analytics: Received FDA 510(k) clearance for MuscleView, an AI-powered muscle health analysis tool.
  • Sydney Neuroimaging Analysis Center: Secured funding for AI software to analyze brain diseases.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment.

Yusuf Yesil, MD, MIS
Yusuf Yesil, MD, MIS

Founder & Medical Doctor at Yesil Science. Clinical Biochemistry Specialist and Health AI researcher focused on clinical decision support, diagnostic AI, and biomedical machine learning.

Follow AI Health Hub